Heart Test Laboratories (HSCS) Market Capitalization

Heart Test Laboratories is actively scaling the implementation of neural networks in ECG, developing the MyoVista system for precision screening of cardiac pathologies by 2026. AI-driven automation of primary data analysis minimizes the need for cardiologists. This chart of market capitalization changes reflects 0.01. Device production is based on a fabless approach, with platform assembly entrusted to US contract manufacturers.

HSCS HeartSciences: Market Capitalization in the range 04/28/2023 - 11/11/2026

HSCS (Heart Test Labs): analytical breakdowns and indicator data

- market price and analyst price targets:

Price Chart HeartSciences|HSCS - Analyst Median Target

- market capitalization details:

Market Capitalization Heart Test Labs|HSCS - Real Price to Acquire Entire Company

- issuer book value statistics:

Net Assets per Single Share HeartSciences|HSCS - Book Valuation of Business|Market Value to Book Value Ratio heartsciences.com|HSCS - Cumulative Company Assets

- debt level and financial liquidity data:

- business earnings and investment ratios data:

HSCS - Net Profit|Expected Profit Heart Test Laboratories|HSCS - Price to Earnings Ratio|Projected Price to Earnings Heart Test Laboratories Inc.|HSCS - Price to Earnings Adjusted for Growth Rate|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Heart Test Labs|HSCS - Operating income before deduction of amortization|Net earnings per share (EPS TTM) HeartSciences|HSCS - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months heartsciences.com|HSCS - Expected net earnings per share growth this year|Earnings growth forecast for next year Heart Test Laboratories

Fundamental company valuation:HeartSciences HSCS

Investors determine the scale of a business through the aggregate value of all issued shares. This metric is calculated as the product of the current price of a single instrument and the total number of securities outstanding. For Heart Test Laboratories (HSCS), it reflects market optimism regarding the implementation of AI diagnostics within hospital networks. The price action of the company's market capitalization signals a trend reversal upon receiving regulatory approvals. Analyzing this chart allows for the timely identification of a reversal in the asset's valuation.

Competitors of Heart Test Laboratories